A new study shows the promise of new approach to treat lung cancer. The need for more effective lung cancer treatments is paramount given that the disease remains a leading cause of cancer deaths in the United States. The new findings by a research team from the Stony Brook Cancer Center highlight a novel therapeutic that is shown to be highly effective in reducing non-small cell lung cancer (NSCLC) tumors and appears to halt drug resistance in …